All Type of News
Obesity treatment Reductil permitted to sell at a market
As a new slimming drug, Reductil capsule is permitted to launch on the market, market for drug of beat obesity will be expanded, one expects.
KFDA announced that they have sanctioned to place new drug Reductil(si...
KPA urges to Complementary measures for Payment of medicine fee
KPA settled the position that they cannot take part in medicine distribution information system without making up for payment way of medicine fee.
KPA discussed the pending problems including medicine distribution ...
30% incentive for substitutive dispensing proven drugs of bio-equivalency.
Effective from July 1 an incentive as much as about 30% of the price balance from the upper limit insurance price will be given to pharmacies when dispensing inexpensive substitutive drug already proven of its bio-eq...
Long-term Prescription Under judgement of doctor be free from limits of days
As integrating medical examination fee with prescription fee as part of measure for insurance financial stabilization on and after July 1, Ministry of Health and Welfare announced that they will abandon the limits on ...
Overall drug price slashes resulted in declined pharmaceutical production value.
Ongoing drug price slashes along with the implementation of the actual purchase price reimbursement system have resulted in about 4% value plunge of the total pharmaceutical production in 2000.
Such a pharmaceutic...
Bio-technology fund to raise up to 50 billion won.
During the second half of this year the government is going to expand the bio-technology fund up to 50 billion won.
The Ministry of Industry and Energy announced the 10 major industrial projects to expand the ventu...
Medical insurance price for Gleevec under review.
The medical insurance price for Gleevec, an anti-cancer drug for the myeloid leukemia began to review at the concerned authority from July 2.
Gleevec completed its health registration from the KFDA on June 28, and ...
Pharmaceutical Law Aborted in June
Amendment of Pharmaceutical Affairs Law placed in the plenary session of National Assembly didn't proceed within the extraordinary session due to political strife between the ruling and opposition parties, was transfe...
Unified opinion to Opposition against Health Insurance Special Law
As medical circles, civic groups as well as the ruling and opposition parties object to introduction of 'special law for sound health insurance finance' prepared to stabilize Health insurance financial, it is far from...
Unfair Claim expanded on business suspending 1 year
Period of service suspension according to unfair claim of healthcare institutions has been increased from 90 days to 1 year, and standards of penalty levy has been intensified to 4~5 times of total amount of unfair cl...
